X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
6-hydroxydopamine (4906) 4906
animals (4421) 4421
rats (3607) 3607
neurosciences (3300) 3300
male (2915) 2915
parkinson's disease (1905) 1905
dopamine (1887) 1887
index medicus (1354) 1354
rats, sprague-dawley (1252) 1252
oxidopamine (1226) 1226
parkinsons-disease (1195) 1195
dopamine - metabolism (1090) 1090
pharmacology & pharmacy (964) 964
neurons (933) 933
disease models, animal (823) 823
female (817) 817
brain (794) 794
substantia-nigra (742) 742
rat (722) 722
rats, wistar (712) 712
striatum (704) 704
basal ganglia (684) 684
humans (682) 682
oxidopamine - toxicity (644) 644
motor activity - drug effects (638) 638
corpus striatum - drug effects (627) 627
mice (621) 621
oxidopamine - pharmacology (618) 618
hydroxydopamines - pharmacology (604) 604
corpus striatum - metabolism (595) 595
rats, inbred strains (595) 595
substantia nigra (591) 591
6-hydroxydopamine lesions (586) 586
oxidative stress (557) 557
biochemistry & molecular biology (518) 518
neurons - drug effects (507) 507
dopamine - physiology (506) 506
substantia nigra - drug effects (478) 478
dose-response relationship, drug (475) 475
neurology (466) 466
behavior, animal - drug effects (455) 455
parkinson’s disease (442) 442
tyrosine 3-monooxygenase - metabolism (430) 430
neuroprotection (427) 427
time factors (421) 421
neurodegenerative diseases (418) 418
movement disorders (409) 409
immunohistochemistry (407) 407
neurons - metabolism (394) 394
substantia nigra - metabolism (380) 380
6-ohda (356) 356
apoptosis (355) 355
l-dopa (338) 338
norepinephrine - metabolism (333) 333
analysis (323) 323
behavioral sciences (319) 319
amphetamine (318) 318
neostriatum (316) 316
neurodegeneration (315) 315
neurotoxicity (315) 315
clinical neurology (314) 314
apomorphine - pharmacology (313) 313
rodents (313) 313
apomorphine (306) 306
nervous system (298) 298
nucleus-accumbens (295) 295
brain - drug effects (294) 294
brain - metabolism (293) 293
norepinephrine (287) 287
dopamine receptors (281) 281
parkinsons disease (276) 276
nucleus accumbens (273) 273
dopaminergic-neurons (271) 271
noradrenaline (268) 268
neuroprotective agents - pharmacology (267) 267
psychiatry (266) 266
neurons - physiology (262) 262
parkinson disease - metabolism (261) 261
serotonin (259) 259
substantia nigra - pathology (252) 252
receptors (247) 247
phenols (243) 243
motor activity - physiology (242) 242
ventral tegmental area (241) 241
denervation (240) 240
cell biology (239) 239
levodopa - pharmacology (239) 239
parkinson disease - drug therapy (239) 239
microdialysis (238) 238
6‐hydroxydopamine (237) 237
rotation (237) 237
in-vivo (236) 236
lesions (230) 230
mptp (227) 227
rotational behavior (225) 225
rat-brain (224) 224
expression (222) 222
disease (221) 221
messenger-rna (221) 221
degeneration (220) 220
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6419) 6419
Japanese (31) 31
Chinese (18) 18
Spanish (18) 18
Korean (9) 9
Persian (9) 9
Portuguese (7) 7
German (5) 5
French (4) 4
Russian (3) 3
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 12/2013, Volume 230, Issue 3, pp. 345 - 352
Rationale: Altered cognitive function is a common feature of both the early and later stages of Parkinson's disease (PD) that involves alterations in cortical... 
6-Hydroxydopamine
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 03/2014, Volume 92, Issue 3, pp. 347 - 358
  Parkinson's disease (PD) is a progressive neurodegenerative disorder whose etiology is still unclear in spite of extensive investigations. It has been... 
6-Hydroxydopamine
Journal Article
Neuroscience Letters, ISSN 0304-3940, 06/2013, Volume 544, pp. 15 - 19
A recent in vivo study suggested that the delivery of adipose stromal cells (ASCs) protected rat brains from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity.... 
6-Hydroxydopamine
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 08/2013, Volume 331, Issue 1-2, pp. 31 - 37
Oxidative stress-induced neuronal cell death has been implicated in Parkinson's disease (PD). Oxidative stress initiated by 6-hydroxydopamine (6-OHDA) causes... 
6-Hydroxydopamine
Journal Article
Cellular and Molecular Neurobiology, ISSN 0272-4340, 10/2013, Volume 33, Issue 7, pp. 907 - 919
The glial cell line-derived neurotrophic factor (GDNF) potential as a therapeutic agent for the treatment of Parkinsonas Disease (PD) has been extensively... 
6-Hydroxydopamine
Journal Article
NMR in Biomedicine, ISSN 0952-3480, 01/2013, Volume 26, Issue 1, pp. 43 - 50
The detection of Parkinson's disease (PD) in its preclinical stages prior to outright neurodegeneration is essential to the development of neuroprotective... 
6-Hydroxydopamine
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 02/2013, Volume 47, Issue 1, pp. 123 - 130
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons; however, its crucial mechanism of... 
6-Hydroxydopamine
Journal Article
Neurotoxicity Research, ISSN 1029-8428, 01/2014, Volume 25, Issue 1, pp. 124 - 134
Nuclear receptors (Nurs) represent a large family of gene expression regulating proteins. Gathering evidence indicates an important role for Nurs as... 
6-Hydroxydopamine
Journal Article
Neuropeptides, ISSN 0143-4179, 06/2013, Volume 47, Issue 3, pp. 139 - 147
The hypothalamic neurochemicals neuropeptide Y (NPY), orexin-A (ORX), and oxytocin (OXY) exert glucoregulatory effects upon intracerebral administration,... 
6-Hydroxydopamine
Journal Article
Current Neuropharmacology, ISSN 1570-159X, 07/2013, Volume 11, Issue 4, pp. 430 - 435
Although the exact cause of neuronal loss in Parkinson's disease is not known, evidence points to oxidative stress and the production of reactive oxygen... 
6-Hydroxydopamine
Journal Article
Neuropeptides, ISSN 0143-4179, 10/2012, Volume 46, Issue 5, pp. 183 - 193
Research on Parkinsonas disease (PD) has mainly focused on the degeneration of the dopaminergic neurons of nigro-striatal pathway; however, post-mortem studies... 
6-Hydroxydopamine
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 09/2010, Volume 226, Issue 1-2, pp. 20 - 26
Inflammation is involved in the pathology of Parkinson's disease, a disorder characterised by degeneration of dopaminergic neurons. This study demonstrates... 
6-Hydroxydopamine
Journal Article
Journal of Parkinson's Disease, ISSN 1877-7171, 01/2013, Volume 3, Issue 3, pp. 341 - 349
Background: In Parkinsons disease (PD), bradykinesia, or slowness of movement, only appears after a large striatal dopamine depletion. Compensatory mechanisms... 
6-Hydroxydopamine
Journal Article
PLoS ONE, 09/2013, Volume 8, Issue 9
We explored the impact of Nox-2 in modulating inflammatory-mediated microglial responses in the 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD)... 
6-Hydroxydopamine
Journal Article
PLoS ONE, 09/2013, Volume 8, Issue 9
Amniotic fluid stem cells (AFSCs) are multipotent stem cells that may be used in transplantation medicine. In this study, AFSCs established from amniocentesis... 
6-Hydroxydopamine
Journal Article
PLoS ONE, 08/2013, Volume 8, Issue 8
Objectives We analyzed whether mast cell stabilization by either ketotifen or tranilast could alter either sympathetic or nitrergic innervation function in rat... 
6-Hydroxydopamine
Journal Article
PLoS ONE, 05/2013, Volume 8, Issue 5
Gene regulation remains one of the major challenges for gene therapy in clinical trials. In the present study, we first generated a binary tetracycline-on... 
6-Hydroxydopamine
Journal Article
Biomedical Spectroscopy and Imaging, ISSN 2212-8794, 01/2012, Volume 1, Issue 2, pp. 125 - 136
Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging was used to generate quantitative elemental images of brain sections of mice... 
6-Hydroxydopamine
Journal Article
Neuroscience, ISSN 0306-4522, 10/2017, Volume 361, pp. 144 - 156
The pathological hallmark of Parkinson’s disease (PD) is the progressive degeneration of dopaminergic neurons in the substantia nigra (SNpc), and the resulting... 
neurodegeneration | intracerebroventricular | 6-hydroxydopamine | Parkinson’s disease
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 04/2002, Volume 125, Issue 1-2, pp. 94 - 102
BALB/c mice exposed to acute cold/restraint stress (ACRS) had significantly lower host resistance to Listeria monocytogenes (LM) than controls. The stress... 
6-hydroxydopamine
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.